Prevention and management of medication overuse headache
- 1 June 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Neurology
- Vol. 25 (3), 290-295
- https://doi.org/10.1097/wco.0b013e328352c431
Abstract
Purpose of review This review provides an update on our knowledge regarding prevention and management of medication overuse headache (MOH). Recent findings The prevalence of MOH is 1-2% in the general population worldwide, and because of the tremendous socio-economic cost, it is likely to be the most costly neurological disorder known. MOH has similarities with traditional drug addiction. Use of a brochure on medication overuse can prevent MOH. The Severity of Dependence Scale (SDS) score is a significant predictor of medication overuse among headache patients. Withdrawal of medication is essential in the management of MOH, and simultaneous initiation of prophylactic medication may alleviate this process. Short advice on medication overuse by a physician reduced mean medication days from 22 to 6 days; 76% no longer had medication overuse and 42% no longer had chronic headache. Summary A brochure and/or the SDS should be used to prevent MOH. Withdrawal is the cornerstone of MOH management. Short advice on MOH is the current most cost effective management method, a method that can be applied anywhere including third world countries.Keywords
This publication has 35 references indexed in Scilit:
- Dependence scores predict prognosis of medication overuse headache: A prospective cohort from the Akershus study of chronic headachePain, 2012
- Medication use in patients with migraine and medication-overuse headache: The role of problem-solving and attitudes about pain medicationPain, 2011
- An adapted Severity of Dependence Scale is valid for the detection of medication overuse: the Akershus study of chronic headacheEuropean Journal of Neurology, 2010
- The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headachePain, 2010
- The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headacheJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Prevalence of Secondary Chronic Headaches in a Population-Based Sample of 30-44-Year-Old Persons. The Akershus Study of Chronic HeadacheCephalalgia, 2008
- Epidemiology and comorbidity of headacheThe Lancet Neurology, 2008
- A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Multiple Treatments of Botulinum Toxin Type A (BoNTA) for the Prophylaxis of Episodic Migraine HeadachesCephalalgia, 2007
- Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group StudyCephalalgia, 2006
- Transformed Migraine and Medication Overuse in a Tertiary Headache Centre — Clinical Characteristics and Treatment OutcomesCephalalgia, 2004